Report Detail
Global Oncology Biosimilars Market Insights and Forecast to 2026
- RnM4130904 |
- 12 August, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Oncology Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oncology Biosimilars market is segmented into
mAb
Immunomodulators
Hematopoietic Agents
G-CSF
Others
Segment by Application, the Oncology Biosimilars market is segmented into
Retail Pharmacies
Hospital Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Oncology Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oncology Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oncology Biosimilars Market Share Analysis
Oncology Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Biosimilars business, the date to enter into the Oncology Biosimilars market, Oncology Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Celltrion
Biocon
Dr. Reddy’s Laboratories
STADA Arzneimittel AG
Intas Pharmaceuticals
Pfizer
Sandoz International
Teva Pharmaceutical Industries Ltd
Apotex
BIOCAD
1 Study Coverage
- 1.1 Oncology Biosimilars Product Introduction
- 1.2 Market Segments
- 1.3 Key Oncology Biosimilars Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Oncology Biosimilars Market Size Growth Rate by Type
- 1.4.2 mAb
- 1.4.3 Immunomodulators
- 1.4.4 Hematopoietic Agents
- 1.4.5 G-CSF
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Oncology Biosimilars Market Size Growth Rate by Application
- 1.5.2 Retail Pharmacies
- 1.5.3 Hospital Pharmacy
- 1.5.4 Online Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oncology Biosimilars Market Size, Estimates and Forecasts
- 2.1.1 Global Oncology Biosimilars Revenue 2015-2026
- 2.1.2 Global Oncology Biosimilars Sales 2015-2026
- 2.2 Global Oncology Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Oncology Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Oncology Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oncology Biosimilars Competitor Landscape by Players
- 3.1 Oncology Biosimilars Sales by Manufacturers
- 3.1.1 Oncology Biosimilars Sales by Manufacturers (2015-2020)
- 3.1.2 Oncology Biosimilars Sales Market Share by Manufacturers (2015-2020)
- 3.2 Oncology Biosimilars Revenue by Manufacturers
- 3.2.1 Oncology Biosimilars Revenue by Manufacturers (2015-2020)
- 3.2.2 Oncology Biosimilars Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Oncology Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Oncology Biosimilars Revenue in 2019
- 3.2.5 Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Oncology Biosimilars Price by Manufacturers
- 3.4 Oncology Biosimilars Manufacturing Base Distribution, Product Types
- 3.4.1 Oncology Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oncology Biosimilars Product Type
- 3.4.3 Date of International Manufacturers Enter into Oncology Biosimilars Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Oncology Biosimilars Market Size by Type (2015-2020)
- 4.1.1 Global Oncology Biosimilars Sales by Type (2015-2020)
- 4.1.2 Global Oncology Biosimilars Revenue by Type (2015-2020)
- 4.1.3 Oncology Biosimilars Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Oncology Biosimilars Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Oncology Biosimilars Sales Forecast by Type (2021-2026)
- 4.2.2 Global Oncology Biosimilars Revenue Forecast by Type (2021-2026)
- 4.2.3 Oncology Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Oncology Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Oncology Biosimilars Market Size by Application (2015-2020)
- 5.1.1 Global Oncology Biosimilars Sales by Application (2015-2020)
- 5.1.2 Global Oncology Biosimilars Revenue by Application (2015-2020)
- 5.1.3 Oncology Biosimilars Price by Application (2015-2020)
- 5.2 Oncology Biosimilars Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Oncology Biosimilars Sales Forecast by Application (2021-2026)
- 5.2.2 Global Oncology Biosimilars Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Oncology Biosimilars Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Oncology Biosimilars by Country
- 6.1.1 North America Oncology Biosimilars Sales by Country
- 6.1.2 North America Oncology Biosimilars Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Oncology Biosimilars Market Facts & Figures by Type
- 6.3 North America Oncology Biosimilars Market Facts & Figures by Application
7 Europe
- 7.1 Europe Oncology Biosimilars by Country
- 7.1.1 Europe Oncology Biosimilars Sales by Country
- 7.1.2 Europe Oncology Biosimilars Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oncology Biosimilars Market Facts & Figures by Type
- 7.3 Europe Oncology Biosimilars Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Oncology Biosimilars by Region
- 8.1.1 Asia Pacific Oncology Biosimilars Sales by Region
- 8.1.2 Asia Pacific Oncology Biosimilars Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Oncology Biosimilars Market Facts & Figures by Type
- 8.3 Asia Pacific Oncology Biosimilars Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Oncology Biosimilars by Country
- 9.1.1 Latin America Oncology Biosimilars Sales by Country
- 9.1.2 Latin America Oncology Biosimilars Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Oncology Biosimilars Market Facts & Figures by Type
- 9.3 Central & South America Oncology Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Oncology Biosimilars by Country
- 10.1.1 Middle East and Africa Oncology Biosimilars Sales by Country
- 10.1.2 Middle East and Africa Oncology Biosimilars Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Oncology Biosimilars Market Facts & Figures by Type
- 10.3 Middle East and Africa Oncology Biosimilars Market Facts & Figures by Application
11 Company Profiles
- 11.1 Celltrion
- 11.1.1 Celltrion Corporation Information
- 11.1.2 Celltrion Description and Business Overview
- 11.1.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Celltrion Oncology Biosimilars Products Offered
- 11.1.5 Celltrion Related Developments
- 11.2 Biocon
- 11.2.1 Biocon Corporation Information
- 11.2.2 Biocon Description and Business Overview
- 11.2.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Biocon Oncology Biosimilars Products Offered
- 11.2.5 Biocon Related Developments
- 11.3 Dr. Reddy’s Laboratories
- 11.3.1 Dr. Reddy’s Laboratories Corporation Information
- 11.3.2 Dr. Reddy’s Laboratories Description and Business Overview
- 11.3.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Dr. Reddy’s Laboratories Oncology Biosimilars Products Offered
- 11.3.5 Dr. Reddy’s Laboratories Related Developments
- 11.4 STADA Arzneimittel AG
- 11.4.1 STADA Arzneimittel AG Corporation Information
- 11.4.2 STADA Arzneimittel AG Description and Business Overview
- 11.4.3 STADA Arzneimittel AG Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 STADA Arzneimittel AG Oncology Biosimilars Products Offered
- 11.4.5 STADA Arzneimittel AG Related Developments
- 11.5 Intas Pharmaceuticals
- 11.5.1 Intas Pharmaceuticals Corporation Information
- 11.5.2 Intas Pharmaceuticals Description and Business Overview
- 11.5.3 Intas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Intas Pharmaceuticals Oncology Biosimilars Products Offered
- 11.5.5 Intas Pharmaceuticals Related Developments
- 11.6 Pfizer
- 11.6.1 Pfizer Corporation Information
- 11.6.2 Pfizer Description and Business Overview
- 11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Pfizer Oncology Biosimilars Products Offered
- 11.6.5 Pfizer Related Developments
- 11.7 Sandoz International
- 11.7.1 Sandoz International Corporation Information
- 11.7.2 Sandoz International Description and Business Overview
- 11.7.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Sandoz International Oncology Biosimilars Products Offered
- 11.7.5 Sandoz International Related Developments
- 11.8 Teva Pharmaceutical Industries Ltd
- 11.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
- 11.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
- 11.8.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Products Offered
- 11.8.5 Teva Pharmaceutical Industries Ltd Related Developments
- 11.9 Apotex
- 11.9.1 Apotex Corporation Information
- 11.9.2 Apotex Description and Business Overview
- 11.9.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Apotex Oncology Biosimilars Products Offered
- 11.9.5 Apotex Related Developments
- 11.10 BIOCAD
- 11.10.1 BIOCAD Corporation Information
- 11.10.2 BIOCAD Description and Business Overview
- 11.10.3 BIOCAD Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 BIOCAD Oncology Biosimilars Products Offered
- 11.10.5 BIOCAD Related Developments
- 11.1 Celltrion
- 11.1.1 Celltrion Corporation Information
- 11.1.2 Celltrion Description and Business Overview
- 11.1.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Celltrion Oncology Biosimilars Products Offered
- 11.1.5 Celltrion Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Oncology Biosimilars Market Estimates and Projections by Region
- 12.1.1 Global Oncology Biosimilars Sales Forecast by Regions 2021-2026
- 12.1.2 Global Oncology Biosimilars Revenue Forecast by Regions 2021-2026
- 12.2 North America Oncology Biosimilars Market Size Forecast (2021-2026)
- 12.2.1 North America: Oncology Biosimilars Sales Forecast (2021-2026)
- 12.2.2 North America: Oncology Biosimilars Revenue Forecast (2021-2026)
- 12.2.3 North America: Oncology Biosimilars Market Size Forecast by Country (2021-2026)
- 12.3 Europe Oncology Biosimilars Market Size Forecast (2021-2026)
- 12.3.1 Europe: Oncology Biosimilars Sales Forecast (2021-2026)
- 12.3.2 Europe: Oncology Biosimilars Revenue Forecast (2021-2026)
- 12.3.3 Europe: Oncology Biosimilars Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Oncology Biosimilars Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Oncology Biosimilars Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Oncology Biosimilars Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Oncology Biosimilars Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Oncology Biosimilars Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Oncology Biosimilars Sales Forecast (2021-2026)
- 12.5.2 Latin America: Oncology Biosimilars Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Oncology Biosimilars Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Oncology Biosimilars Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Oncology Biosimilars Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Oncology Biosimilars Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Oncology Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Oncology Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oncology Biosimilars Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oncology Biosimilars. Industry analysis & Market Report on Oncology Biosimilars is a syndicated market report, published as Global Oncology Biosimilars Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Oncology Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
